#semaglutide

New Study Links Weight-Loss Drugs to Serious Eye Conditions and Vision Loss

Weight-loss drugs, particularly GLP-1 medications like semaglutide and tirzepatide, are gaining traction among diabetes and obesity patients in India. While these drugs offer benefits like controlling blood sugar and aiding in weight loss, recent studies have uncovered potential eye health risks. A new study published in JAMA has linked these medications to rare but serious eye conditions, with a focus on optic nerve disorders such as non-arteritic anterior is

Health & Wellness

13 Aug 2025 04:14 AM 766 views

New Study Links Weight-Loss Drugs to Serious Eye Conditions and Vision Loss

Health & Wellness

Wegovy Weight-Loss Injection Now Available in India

Novo Nordisk has launched its groundbreaking weight-loss drug, Wegovy, in India. This semaglutide-based injection promises to help individuals tackle obesity and related heart risks, offering a solution to India's growing health concerns. Available as a once-weekly injection, Wegovy works by mimicking the body's natural GLP-1 hormone, which regulates hunger, reduces cravings, and helps control blood sugar. Clinical trials have shown that Wegovy can res

Health & Wellness

24 Jun 2025 08:38 AM 719 views

Wegovy Weight-Loss Injection Now Available in India

Health & Wellness

Medi-Cal May Drop Ozempic, Wegovy Coverage by 2026

Under a new cost-cutting proposal by Governor Gavin Newsom, California may soon eliminate Medi-Cal coverage for popular weight loss drugs Ozempic and Wegovy, sparking concern among healthcare advocates and low-income patients. The move, which aims to address a $12 billion state budget deficit, could take effect on January 1, 2026, and would save the state an estimated $85 million in 2025–26 and up to $680 million by 2028–29, according to Newsom's office. Ozempic and

Health & Wellness

16 May 2025 10:11 AM 1.39k views

Medi-Cal May Drop Ozempic, Wegovy Coverage by 2026

Health & Wellness

FDA Action on GLP-1 Drugs Sparks Surge in Unproven Weight Loss Supplements

With the U.S. Food and Drug Administration beginning enforcement actions against compounded versions of popular weight loss medications such as semaglutide and tirzepatide—known under their brand names Wegovy and Zepbound—Americans who turned to these affordable alternatives may find themselves eyeing the murky waters of the supplement market. As access to these custom-made medications dwindles due to the end of drug shortages, a wave of unregulated supplements has hit shelves and on

Health & Wellness

22 Apr 2025 07:18 AM 1.01k views

FDA Action on GLP-1 Drugs Sparks Surge in Unproven Weight Loss Supplements

Health & Wellness

Articles

D Gukesh Becomes Highest-Ranked Indian Chess Player, Surpassing Arjun Erigaisi

BCCI Rejected Rohit Sharma's Dhoni-Style Test Exit: Report

AAI Recruitment 2025: Apply for 224 Junior & Senior Assistant Posts

Dixon woman welcomes nearly 13-pound newborn in record-breaking delivery

Bears Star D.J. Moore Hospitalized After Win, Stays in D.C. for Evaluation

Alibaba Launches QVQ-72B: Vision-Based AI with Advanced Reasoning

Golden Globes 2025 Highlights: Top Winners in Film and TV

Knee Surgery Risks Higher for Diabetics, Study Warns

Political Tensions Rise in Maharashtra Over MNS Protest in Thane

New Jersey secures $800 million settlement with DuPont for toxic contamination

#semaglutide

New Study Links Weight-Loss Drugs to Serious Eye Conditions and Vision Loss

New Study Links Weight-Loss Drugs to Serious Eye Conditions and Vision Loss

Wegovy Weight-Loss Injection Now Available in India

Wegovy Weight-Loss Injection Now Available in India

Medi-Cal May Drop Ozempic, Wegovy Coverage by 2026

Medi-Cal May Drop Ozempic, Wegovy Coverage by 2026

FDA Action on GLP-1 Drugs Sparks Surge in Unproven Weight Loss Supplements

FDA Action on GLP-1 Drugs Sparks Surge in Unproven Weight Loss Supplements

D Gukesh Becomes Highest-Ranked Indian Chess Player, Surpassing Arjun Erigaisi

BCCI Rejected Rohit Sharma's Dhoni-Style Test Exit: Report

AAI Recruitment 2025: Apply for 224 Junior & Senior Assistant Posts

Dixon woman welcomes nearly 13-pound newborn in record-breaking delivery

Bears Star D.J. Moore Hospitalized After Win, Stays in D.C. for Evaluation

Alibaba Launches QVQ-72B: Vision-Based AI with Advanced Reasoning

Golden Globes 2025 Highlights: Top Winners in Film and TV

Knee Surgery Risks Higher for Diabetics, Study Warns

Political Tensions Rise in Maharashtra Over MNS Protest in Thane

New Jersey secures $800 million settlement with DuPont for toxic contamination

Popular Cities

Sign In

D Gukesh Becomes Highest-Ranked Indian Chess Player, Surpassing Arjun Erigaisi

BCCI Rejected Rohit Sharma's Dhoni-Style Test Exit: Report

AAI Recruitment 2025: Apply for 224 Junior & Senior Assistant Posts

Dixon woman welcomes nearly 13-pound newborn in record-breaking delivery

Bears Star D.J. Moore Hospitalized After Win, Stays in D.C. for Evaluation

Alibaba Launches QVQ-72B: Vision-Based AI with Advanced Reasoning

Golden Globes 2025 Highlights: Top Winners in Film and TV

Knee Surgery Risks Higher for Diabetics, Study Warns

Political Tensions Rise in Maharashtra Over MNS Protest in Thane

New Jersey secures $800 million settlement with DuPont for toxic contamination

#semaglutide

New Study Links Weight-Loss Drugs to Serious Eye Conditions and Vision Loss

New Study Links Weight-Loss Drugs to Serious Eye Conditions and Vision Loss

Wegovy Weight-Loss Injection Now Available in India

Wegovy Weight-Loss Injection Now Available in India

Medi-Cal May Drop Ozempic, Wegovy Coverage by 2026

Medi-Cal May Drop Ozempic, Wegovy Coverage by 2026

FDA Action on GLP-1 Drugs Sparks Surge in Unproven Weight Loss Supplements

FDA Action on GLP-1 Drugs Sparks Surge in Unproven Weight Loss Supplements

D Gukesh Becomes Highest-Ranked Indian Chess Player, Surpassing Arjun Erigaisi

BCCI Rejected Rohit Sharma's Dhoni-Style Test Exit: Report

AAI Recruitment 2025: Apply for 224 Junior & Senior Assistant Posts

Dixon woman welcomes nearly 13-pound newborn in record-breaking delivery

Bears Star D.J. Moore Hospitalized After Win, Stays in D.C. for Evaluation

Alibaba Launches QVQ-72B: Vision-Based AI with Advanced Reasoning

Golden Globes 2025 Highlights: Top Winners in Film and TV

Knee Surgery Risks Higher for Diabetics, Study Warns

Political Tensions Rise in Maharashtra Over MNS Protest in Thane

New Jersey secures $800 million settlement with DuPont for toxic contamination

Popular Cities